Cited by 148Statistical Methods in Clinical TrialsOptimal Experimental Design MethodsAdvanced Causal Inference Techniques

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview

McEntegart, Damian J.·2003·Drug Information Journal

DOI 10.1177/009286150303700305

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1177/009286150303700305

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Residuals and Influence in Regression
Ling, R. F., Cook, R. D., & Weisberg, S. (1984) · Technometrics · doi:10.2307/1269506 · Cited by 2,875
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167
Allocation concealment in randomised trials: defending against deciphering
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07750-4 · Cited by 923
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
(1992) · The Lancet · doi:10.1016/0140-6736(92)91893-d · Cited by 916
ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION
Hunt, D. U., Varigos, G., Dienstl, F., Lechleitner, P., DeBacker, G., Kornitzer, M., Cairns, J., Turpie, A. G. G., Fritz-Hansen, P., Skagen, K., et al. (1992) · The Lancet · Cited by 894
Minimization: A new method of assigning patients to treatment and control groups
Taves, D. R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974155443 · Cited by 891
Forcing a sequential experiment to be balanced
EFRON, B. (1971) · Biometrika · doi:10.1093/biomet/58.3.403 · Cited by 873
Generation of allocation sequences in randomised trials: chance, not choice
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07683-3 · Cited by 774
The method of minimization for allocation to clinical trials
Scott, N. W., McPherson, G. C., Ramsay, C. R., & Campbell, M. K. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00242-8 · Cited by 651
Stratified Randomization for Clinical Trials
Kernan, W. N., Viscoli, C. M., Makuch, R. W., Brass, L. M., & Horwitz, R. I. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00138-3 · Cited by 627
Residuals and Influence in Regression.
Chatterjee, S., Cook, R. D., & Weisberg, S. (1984) · Journal of the American Statistical Association · doi:10.2307/2288741 · Cited by 623
The randomization and stratification of patients to clinical trials
Zelen, M. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90015-0 · Cited by 614
Properties of the urn randomization in clinical trials
Wei, L. J., & Lachin, J. M. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90048-7 · Cited by 308
Combining different phases in the development of medical treatments within a single trial
Bauer, P., & Kieser, M. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990730)18:14 · Cited by 289
Randomization in clinical trials: Conclusions and recommendations
Lachin, J. M., Matts, J. P., & Wei, L. J. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90049-9 · Cited by 272
An application of an urn model to the design of sequential controlled clinical trials.
Wei, L. J. (1978) · Journal of the American Statistical Association · doi:10.1080/01621459.1978.10480054 · Cited by 271
Optimum Biased Coin Designs for Sequential Clinical Trials with Prognostic factors
Atkinson, A. C. (1982) · Biometrika · doi:10.1093/biomet/69.1.61 · Cited by 270
Unequal group sizes in randomised trials: guarding against guessing
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08029-7 · Cited by 250
Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial
CAESAR Coordinating Committee, [., Study group members AMC, :., Kroon, E. D. M. B., & Wit, F. W. N. M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04441-3 · Cited by 245
A Treatment Allocation Procedure for Sequential Clinical Trials
Begg, C. B., & Iglewicz, B. (1980) · Biometrics · doi:10.2307/2530497 · Cited by 220
Statistical properties of randomization in clinical trials
Lachin, J. M. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90045-1 · Cited by 200
Restricted Randomization Designs in Clinical Trials
Simon, R. M. (1979) · Biometrics · doi:10.2307/2530354 · Cited by 178
Encyclopedia of Biopharmaceutical Statistics
Chow, S. (2010) · Informa Healthcare eBooks · doi:10.3109/9781439822463 · Cited by 150
Dynamic balanced randomization for clinical trials
Signorini, D. F., Leung, O. K., Simes, R. J., Beller, E., Gebski, V., & Callaghan, T. (1993) · Statistics in Medicine · doi:10.1002/sim.4780122410 · Cited by 141
How many stratification factors are “too many” to use in a randomization plan?
Therneau, T. M. (1993) · Controlled Clinical Trials · doi:10.1016/0197-2456(93)90013-4 · Cited by 136
On the Use of Pocock and Simon's Method for Balancing Treatment Numbers over Prognostic Factors in the Controlled Clinical Trial
Freedman, L. S., & White, S. J. (1976) · Biometrics · doi:10.2307/2529759 · Cited by 131
Patient subsets and variation in therapeutic efficacy.
Simon, R. M. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb02015.x · Cited by 130
A Method of Biased Coin Randomization, Its Implementation, and Its Validation
Frane, J. W. (1998) · Drug Information Journal · doi:10.1177/009286159803200213 · Cited by 121
Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial
Weir, C. J., & Lees, K. R. (2003) · Statistics in Medicine · doi:10.1002/sim.1366 · Cited by 102
ISSUES RELATED TO SUBGROUP ANALYSIS IN CLINICAL TRIALS
Cui, L., Hung, H., Wang, S., & Tsong, Y. (2002) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-120014565 · Cited by 77
Encyclopedia of Biopharmaceutical Statistics
(2001) · Technometrics · doi:10.1198/tech.2001.s580 · Cited by 75
The choice of a balanced allocation method for a clinical trial in otitis media with effusion
Zielhuis, G. A., Straatman, H., Hof‐Grootenboer, A. E. V., van Lier, H. J. J., Rach, G. H., & van den Broek, P. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090306 · Cited by 70
A note on stratifying versus complete random assignment in clinical trials
Grizzle, J. E. (1982) · Controlled Clinical Trials · doi:10.1016/0197-2456(82)90026-5 · Cited by 67
The effect of stratified randomization on size and power of statistical tests in clinical trials
Green, S. B., & Byar, D. P. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90008-5 · Cited by 63
Adaptive Biased Urn Randomization in Small Strata When Blinding Is Impossible
Schouten, H. J. A. (1995) · Biometrics · doi:10.2307/2533283 · Cited by 62
Imbalance in treatment assignments in stratified blocked randomization
Hallstrom, A., & Davis, K. B. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90050-5 · Cited by 61
The impact of treatment allocation procedures on nominal significance levels and bias
Kalish, L. A., & Begg, C. B. (1987) · Controlled Clinical Trials · doi:10.1016/0197-2456(87)90037-7 · Cited by 51
Post-Stratification in the Randomized Clinical Trial
McHugh, R., & Matts, J. P. (1983) · Biometrics · doi:10.2307/2530821 · Cited by 51
Adjustment of Treatment Effect for Covariates in Clinical Trials: Statistical and Regulatory Issues
Tu, D., Shalay, K., & Pater, J. L. (2000) · Drug Information Journal · doi:10.1177/009286150003400220 · Cited by 50
Magnitude and likelihood of loss resulting from non‐stratified randomization
Palta, M., & Amini, S. B. (1982) · Statistics in Medicine · doi:10.1002/sim.4780010308 · Cited by 16
Randomization in cancer clinical trials: permutation test and development of a computer program.
Ohashi, Y. (1990) · Environmental Health Perspectives · doi:10.1289/ehp.908713 · Cited by 15
USING A BALANCING PROCEDURE IN MULTICENTER CLINICAL TRIALS
Rovers, M. M., Straatman, H., Zielhuis, G. A., Ingels, K. J. A. O., & van der Wilt, G. J. (2000) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300161239 · Cited by 12
Investigating Maximum Power Losses in Survival Studies with Nonstratified Randomization
Palta, M. (1985) · Biometrics · doi:10.2307/2530874 · Cited by 11
A random allocation system with the minimization method for multi-institutional clinical trials
Akazawa, K., Odaka, T., Sakamoto, M., Ohtsuki, S., Shimada, M., Kamakura, T., & Nose, Y. (1991) · Journal of Medical Systems · doi:10.1007/bf00999168 · Cited by 9
Dynamic Treatment Allocation Adjusting for Prognostic Factors for More Than Two Treatments
Dror, S., Faraggi, D., & Reiser, B. (1995) · Biometrics · doi:10.2307/2533264 · Cited by 5

Research works printed but not linked: 11

International Conference un Harmonisation. Guidance on Statistical Principles Tor Clinical Trials. Federal Register. International Confer-ence on Harmonisation; E-9 Document. 1998: Vol.63, 179:49583–49598.
Atkinson A. Beyond the platinum standard; ran-domisation and balancing covartales in sequential multi-center trials. Henry Stewart Conference on Statistics of Multi-center Trials. January 25, 2002. London.
Cox DR. Randomization and concomitant variables in the design of experinents. In: Kallianpur G, Krishnaiah PR, Ghosh JK eds. Statistics and Probability: Essaya in Honor of Rao CR. Amsterdam, Holland: North Holland Publishing Company: 1982:197–202.
ISIS-4 Collaborative Group. 1S1S-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 subjects with suspected myocardial infarction. Lancet. 1995:349:1413–1421.
Reed JV, Wickham EA. Practical experience of minimization in clinical trials. Pharmaceut Med. 1988:3:349–359.
Quinaux E, Buyse M, Choosing an optimal treatment allocation method in randomised clinical trials (poster). Presented at the Drug Information Association Annual Meeting. Chicago, IL, 2001.
Ebbutt A, Kay R, McNamara J, Engler J, The analy-sis of trials using a minimization algorithm. In: 20th Anniversary Conference Report. Macclesfield, England: PSI; 1998:12–14.
Dowlman N. Intelligent medication manage-ment—using IVR to optimise the drug supply process, Pharma Manufactur Pack Sourcer. 2001:Summer;24–28.
Dowlman N. The cost benefits of using 1VR sys-tems in the supply chain. Pharma Manufactur Pack Sourcer. 2001;Autumn:74–79.
Byrom B. Using IVRS in clinical trial management. Appl Clin Trials. 2002:10:36–42.
Food and Drug Adminstration. 21 CFR Part 11. Electronic Records; Electronic Signatures. Federal Register. 1997; Vol. 62. 54:13430–13466.

Sorted by citations

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106668 · Cited by 782
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
Castro, M., Rubin, A. S., Laviolette, M., Fiterman, J., Lima, M. D. A., Shah, P. L., Fiss, E., Olivenstein, R., Thomson, N. C., Niven, R. M., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0354oc · Cited by 670
Issues in Outcomes Research: An Overview of Randomization Techniques for Clinical Trials
Kang, M., Ragan, B. G., & Park, J.-H. (2008) · Journal of Athletic Training · doi:10.4085/1062-6050-43.2.215 · Cited by 555
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial
Walker, I., Panzarella, T., Couban, S., Couture, F., Devins, G. M., Elemary, M., Gallagher, G., Kerr, H. M., Kuruvilla, J. G., Lee, S. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00462-3 · Cited by 365

See all 148

Authors: McEntegart, D. J.
Corresponding author: McEntegart, Damian J.
Venue: Drug Information Journal
Publisher: Springer Science and Business Media LLC
Published: 2003-07
Volume: 37
Issue: 3
Pages: 293-308
ISSN: 0092-8615 (ISSN-L)
2164-9200
DOI: 10.1177/009286150303700305
OpenAlex: W2011792098
Cited by: 145
References: 49
Citations by year: 2026: 3 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 2 · 2019: 3 · 2018: 1 · 2016: 7 · 2015: 8 · 2014: 13 · 2013: 12 · 2012: 17
FWCI: 3.78
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Drug Information Journal (publishedVersion)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
Keywords: stratified randomization, prognostic factors, statistical efficiency, minimization, optimal allocation, drug supply

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks